A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
- Status
- TERMINATED
- Phase
- PHASE2
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
- Status
- RECRUITING
- Phase
- PHASE2
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ASP1002 in Adults for Treatment of Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
- Status
- TERMINATED
- Phase
- PHASE4
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3